The administration of 50 μl of 0.5% OMT led to marked increase in the antioxidant levels of CAT (p < 0.001, p < 0.001, p < 0.001), SOD (p < 0.001, p < 0.001, p < 0.001), GPx (p < 0.05, p < 0.001), and GSH (p < 0.001, p < 0.01, p < 0.01) when compared to the normal, glaucoma control, and standard groups, respectively. The gene discussed is GSS; the disease is glaucoma.